Skip to content
MedsAcross

Medicine

Oseltamivir 45 mg capsule

Oseltamivir · Oral
Available on requestPrescription onlyUS FDAGeneric name

Oseltamivir 45 mg capsule is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store the capsules at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to…

Key facts

Active ingredient (INN)
Oseltamivir
Brand
Sold under the generic name
Strength
45 mg
Dosage form
Capsule
Route
Oral
Packs
1 carton, 1 blister pack, 10 capsules and 25 more
Manufacturers
Alembic PharmaceuticalsIndiaLaurus LabsIndiaZydus LifesciencesIndiaCamber PharmaceuticalsIndiaLupinIndiaMacleods PharmaceuticalsIndiaNovadoz PharmaceuticalsIndiaStrides PharmaIndiaEpic PharmaProficient Rx21 labelers on the register
Origin register
US FDA, United States
Storage
Store the capsules at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to 86ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J05AH02 Oseltamivir
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 December 2016
Identifiers
RxCUI 312122, 728109, 728113DailyMed set ID c456f293-daf7-46b1-bffc-5ca234adbb70, 00e2e995-6296-b544-e063-6294a90a8345, 927cba3a-62cf-4e9f-9871-92835927ea46 +23NDC 72205-043, 0527-4592, 42385-986 +23Application ANDA212544, ANDA212739, ANDA218565 +12

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 carton in 1 blister pack / 10 capsule in 1 carton46708-414-10Alembic PharmaceuticalsIndia25 June 2019
1 carton in 1 blister pack / 10 capsule in 1 carton62332-414-10Alembic PharmaceuticalsIndia25 June 2019
1 blister pack in 1 carton / 10 capsule in 1 blister pack70710-1009-2Zydus LifesciencesIndia24 February 2017
1 blister pack in 1 carton / 10 capsule in 1 blister pack70771-1711-2Zydus LifesciencesIndia24 February 2017
10 capsule in 1 carton31722-631-31Camber PharmaceuticalsIndia23 February 2018
100 capsule in 1 bottle42385-986-01Laurus LabsIndia2 May 2024
1 blister pack in 1 carton / 10 capsule in 1 blister pack42385-986-11Laurus LabsIndia2 May 2024
1 blister pack in 1 carton / 10 capsule in 1 blister pack68180-676-11LupinIndia9 February 2018
1 blister pack in 1 carton / 10 capsule in 1 blister pack33342-257-66Macleods PharmaceuticalsIndia21 September 2017
1 blister pack in 1 carton / 10 capsule in 1 blister pack72205-043-11Novadoz PharmaceuticalsIndia25 August 2020
10 capsule in 1 blister pack64380-798-01Strides PharmaIndia5 October 2018
1 blister pack in 1 carton / 10 capsule in 1 blister pack47781-469-13Alvogen12 December 2016
1 blister pack in 1 carton / 10 capsule in 1 blister pack60219-1265-1Amneal Pharmaceuticals27 September 2022
1 blister pack in 1 carton / 10 capsule in 1 blister pack69238-1265-1Amneal Pharmaceuticals NY21 May 2017
100 capsule in 1 bottle42806-554-01Epic Pharma4 December 2023
10 capsule in 1 bottle42806-554-11Epic Pharma4 December 2023
10 capsule in 1 blister pack42806-554-80Epic Pharma1 October 2021
10 capsule in 1 blister pack76282-703-45Exelan Pharmaceuticals1 December 2023
1 blister pack in 1 carton / 10 capsule in 1 blister pack0527-4592-13Lannett15 May 2023
1 blister pack in 1 carton / 10 capsule in 1 blister pack42677-321-01Shandong New Time Pharmaceutical9 July 2025
1 blister pack in 1 carton / 10 capsule in 1 blister pack72673-102-10Zhejiang Poly Pharm31 December 2025
10 capsule in 1 bottle71205-360-10Proficient Rx1 November 2019
1 blister pack in 1 carton / 10 capsule in 1 blister pack71205-417-10Proficient Rx3 March 2020
10 capsule in 1 carton71205-680-10Proficient Rx4 August 2022
10 capsule in 1 carton85766-083-10Sportpharm24 October 2025
10 capsule in 1 blister pack85766-145-10Sportpharm11 February 2026
10 capsule in 1 carton76420-290-10Asclemed23 September 2022
1 blister pack in 1 carton / 10 capsule in 1 blister pack68071-3741-1NuCare Pharmaceuticals9 December 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 27 October 1999Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Oseltamivir

Clinical summary

Oseltamivir is a neuraminidase inhibitor indicated for treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, among other approved uses. MedsAcross supplies Oseltamivir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Oseltamivir

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Oseltamivir 45 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.